Early Access

10-QPeriod: Q3 FY2010

HCA Healthcare, Inc. Quarterly Report for Q3 Ended Sep 30, 2010

Filed November 9, 2010For Securities:HCA

Summary

This Form 10-Q for the period ending September 29, 2010, provides an update on HCA Healthcare, Inc.'s (HCA) operational and legal status. A key point for investors is the company's ongoing engagement with legal and regulatory matters, a common characteristic of the healthcare industry. While HCA reported that its Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) expired in January 2009 and was formally accepted in April 2010, thereby relieving them of future obligations under that specific agreement, the potential for future government scrutiny or private 'qui tam' actions remains. Investors should note that the resolution of such legal proceedings, particularly those involving government investigations, could materially impact HCA's financial position, results of operations, and liquidity. Furthermore, the filing details an amended and restated joinder agreement for HCA's senior secured revolving credit facility, establishing a new credit series maturing in November 2015. The effectiveness of these new credit facilities is contingent upon the company receiving proceeds from an initial public offering (IPO) or a specified date in May 2012, with potential adjustments to credit margins based on leverage ratios. This indicates a potential path towards an IPO and the company's focus on its capital structure as it navigates the regulatory landscape.

Financial Statements
Beta
Revenue$6.93B
Interest Expense$525.00M
Net Income$243.00M
EPS (Basic)$0.57
EPS (Diluted)$0.55
Shares Outstanding (Basic)426.36M
Shares Outstanding (Diluted)439.03M

Key Highlights

  • 1HCA's Corporate Integrity Agreement (CIA) with the OIG expired in January 2009 and was accepted in April 2010, relieving the company of specific future obligations under that agreement.
  • 2Despite the CIA's expiration, HCA acknowledges the ongoing risk of government investigations, legal proceedings, and 'qui tam' (whistleblower) suits, which could materially affect financial results.
  • 3The company has entered into an amended and restated joinder agreement for its senior secured revolving credit facility, establishing a new series maturing November 17, 2015.
  • 4The new revolving credit facility's effectiveness is linked to the proceeds from an initial public offering (IPO) or a specific date in May 2012.
  • 5There were no material changes to previously disclosed risk factors, and disclosure controls and procedures were deemed effective by management.
  • 6HCA repurchased a nominal amount of 60 shares of common stock during the third quarter of 2010, primarily related to employee agreements.

Frequently Asked Questions